However, it’s important to keep expectations realistic . Most of these studies are still in the early or preclinical stages. This means:
Human studies are still limited or ongoing
Long-term safety has not yet been fully confirmed
Effectiveness in patients in real-world settings requires confirmation
Although this is a promising finding, it is not yet an available treatment.
Nevertheless, the direction of this research represents a significant shift from managing bone loss to potentially rebuilding bone tissue itself.
From slowing the aging process… to rebuilding strength. The future of bone health may be closer than we think.